Cargando…

Anti-Kir4.1 Antibodies in Multiple Sclerosis: Specificity and Pathogenicity

The glial cells in the central nervous system express diverse inward rectifying potassium channels (Kir). They express multiple Kir channel subtypes that are likely to have distinct functional roles related to their differences in conductance, and sensitivity to intracellular and extracellular facto...

Descripción completa

Detalles Bibliográficos
Autores principales:	Imamura, Michie, Higuchi, Osamu, Maeda, Yasuhiro, Mukaino, Akihiro, Ueda, Mitsuharu, Matsuo, Hidenori, Nakane, Shunya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765826/ https://www.ncbi.nlm.nih.gov/pubmed/33348803 http://dx.doi.org/10.3390/ijms21249632

Ejemplares similares

Lack of KIR4.1 autoantibodies in Japanese patients with MS and NMO
por: Higuchi, Osamu, et al.
Publicado: (2016)

Detecting gastrointestinal manifestations in patients with systemic sclerosis using anti-gAChR antibodies
por: Nakane, Shunya, et al.
Publicado: (2020)

Ganglionic Acetylcholine Receptor Antibodies and Autonomic Dysfunction in Autoimmune Rheumatic Diseases
por: Imamura, Michie, et al.
Publicado: (2020)

gAChR antibodies in children and adolescents with acquired autoimmune dysautonomia in Japan
por: Yamakawa, Makoto, et al.
Publicado: (2021)

Effectiveness of treatment for 31 patients with seropositive autoimmune autonomic ganglionopathy in Japan
por: Hayashi, Toshiyuki, et al.
Publicado: (2022)

Association between Anti-Ganglionic Nicotinic Acetylcholine Receptor (gAChR) Antibodies and HLA-DRB1 Alleles in the Japanese Population
por: Maeda, Yasuhiro, et al.
Publicado: (2016)

Autoimmune postural orthostatic tachycardia syndrome
por: Watari, Mari, et al.
Publicado: (2018)

KIR4.1 Antibodies as Biomarkers in Multiple Sclerosis
por: Wunsch, Marie, et al.
Publicado: (2014)

Association between neurosarcoidosis with autonomic dysfunction and anti-ganglionic acetylcholine receptor antibodies
por: Oishi, Makoto, et al.
Publicado: (2021)

Clinical Features of Autoimmune Autonomic Ganglionopathy and the Detection of Subunit-Specific Autoantibodies to the Ganglionic Acetylcholine Receptor in Japanese Patients
por: Nakane, Shunya, et al.
Publicado: (2015)

Autoantibodies to Potassium Channel KIR4.1 in Multiple Sclerosis
por: Schneider, Raphael
Publicado: (2013)

Absence of antibodies against KIR4.1 in multiple sclerosis: A three-technique approach and systematic review
por: Navas-Madroñal, Miquel, et al.
Publicado: (2017)

Myasthenic symptoms in anti-low-density lipoprotein receptor-related protein 4 antibody-seropositive amyotrophic lateral sclerosis: two case reports
por: Takahashi, Hisashi, et al.
Publicado: (2016)

KIR4.1: K(+) Channel Illusion or Reality in the Autoimmune Pathogenesis of Multiple Sclerosis
por: Gu, Chen
Publicado: (2016)

Behçet's Disease with Severe Autonomic Disorders Developing after Herpes Zoster
por: Koto, Serina, et al.
Publicado: (2020)

Late-onset Myasthenia Gravis Accompanied by Amyotrophic Lateral Sclerosis with Antibodies against the Acetylcholine Receptor and Low-density Lipoprotein Receptor-related Protein 4
por: Ohnari, Keiko, et al.
Publicado: (2018)

A novel murine model of autoimmune dysautonomia by α3 nicotinic acetylcholine receptor immunization
por: Yamakawa, Makoto, et al.
Publicado: (2022)

EAST/SeSAME Syndrome and Beyond: The Spectrum of Kir4.1- and Kir5.1-Associated Channelopathies
por: Lo, Jacky, et al.
Publicado: (2022)

Kir5.1 underlies long-lived subconductance levels in heteromeric Kir4.1/Kir5.1 channels from Xenopus tropicalis
por: Shang, Lijun, et al.
Publicado: (2009)

Expression of Kir4.1 and Kir5.1 inwardly rectifying potassium channels in oligodendrocytes, the myelinating cells of the CNS
por: Brasko, C., et al.
Publicado: (2016)

Oligodendrocyte-encoded Kir4.1 function is required for axonal integrity
por: Schirmer, Lucas, et al.
Publicado: (2018)

Kir4.1 Dysfunction in the Pathophysiology of Depression: A Systematic Review
por: Della Vecchia, Stefania, et al.
Publicado: (2021)

Kir4.1 is coexpressed with stemness markers in activated astrocytes in the injured brain and a Kir4.1 inhibitor BaCl(2) negatively regulates neurosphere formation in culture
por: Kwon, Jae-Kyung, et al.
Publicado: (2021)

Biophysical and Molecular Mechanisms Underlying the Modulation of Heteromeric Kir4.1–Kir5.1 Channels by Co(2) and Ph
por: Yang, Zhenjiang, et al.
Publicado: (2000)

Non-equivalent role of TM2 gating hinges in heteromeric Kir4.1/Kir5.1 potassium channels
por: Shang, Lijun, et al.
Publicado: (2007)

Calcineurin inhibitors stimulate Kir4.1/Kir5.1 of the distal convoluted tubule to increase NaCl cotransporter
por: Zhang, Dan-Dan, et al.
Publicado: (2023)

The Neuroglial Potassium Cycle during Neurotransmission: Role of Kir4.1 Channels
por: Sibille, Jérémie, et al.
Publicado: (2015)

MeCP2 Deficiency Leads to Loss of Glial Kir4.1
por: Kahanovitch, Uri, et al.
Publicado: (2018)

Metformin Corrects Abnormal Circadian Rhythm and Kir4.1 Channels in Diabetes
por: Alex, Alpha, et al.
Publicado: (2020)

Role of Astrocytic Inwardly Rectifying Potassium (Kir) 4.1 Channels in Epileptogenesis
por: Kinboshi, Masato, et al.
Publicado: (2020)

Inwardly rectifying potassium channels (Kir) in central nervous system glia: a special role for Kir4.1 in glial functions
por: Butt, Arthur M, et al.
Publicado: (2006)

Astrocytic Kir4.1 channels and gap junctions account for spontaneous epileptic seizure
por: Du, Mengmeng, et al.
Publicado: (2018)

Antiepileptic Drugs Elevate Astrocytic Kir4.1 Expression in the Rat Limbic Region
por: Mukai, Takahiro, et al.
Publicado: (2018)

Emerging Roles of Astrocyte Kir4.1 Channels in the Pathogenesis and Treatment of Brain Diseases
por: Ohno, Yukihiro, et al.
Publicado: (2021)

KIR/HLA Interactions and Pathogen Immunity
por: Jamil, Khaleel M., et al.
Publicado: (2011)

Double Seronegative Myasthenia Gravis with Anti-LRP4 Antibodies Presenting with Dropped Head and Acute Respiratory Insufficiency
por: Beck, Goichi, et al.
Publicado: (2016)

Anti-Kv1.4 Antibody Without Myasthenia Gravis: A Rare Cause of Autoimmune Myocarditis and Myositis
por: Kuyama, Naoto, et al.
Publicado: (2023)

Kir4.1-Dependent Astrocyte-Fast Motor Neuron Interactions Are Required for Peak Strength
por: Kelley, Kevin W., et al.
Publicado: (2018)

Kir4.1 may represent a novel therapeutic target for diabetic retinopathy (Review)
por: Li, Xiaoyu, et al.
Publicado: (2021)

Kir4.1 channel activation in NG2 glia contributes to remyelination in ischemic stroke
por: Hong, Xiaoqi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vo1ja2dkdl0273fvt9c8tpjnkr